Please try another search
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to establish the patient’s prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Name | Age | Since | Title |
---|---|---|---|
Hany Massarany | 62 | 2020 | Independent Director |
Paul A. Bunn | 78 | - | Member of Scientific Advisory Board |
Matthew W. Strobeck | 51 | 2012 | Independent Director |
Jean M. Franchi | 58 | 2020 | Independent Director |
David P. Carbone | - | - | Member of Scientific Advisory Board |
John Patience | 76 | 2008 | Independent Chairman |
Jack W. Schuler | 84 | 2008 | Independent Director |
Craig Whitehouse | - | - | Member of Scientific Advisory Board |
Charles McDonald Watts | 81 | 2019 | Independent Director |
Scott Hutton | 52 | 2018 | President, CEO & Director |
John Faiz Kayyem | 60 | 2021 | Independent Director |
Lair Kennedy | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review